Diabetes drug dulaglutide may reduce symptoms of depression

The Sil­i­con Val­ley ven­ture firm An­dreessen Horowitz in re­cent years has been in­vest­ing heav­i­ly in health­care and biotech, guid­ed by its well-known mantra that “soft­ware

The FDA is re­open­ing the com­ment pe­ri­od on its dis­cus­sion pa­per on us­ing ar­ti­fi­cial in­tel­li­gence in drug de­vel­op­ment, co­in­cid­ing with a two-day work­shop on the